微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.4% | 20.53% | 98.76% | 57/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.22% | -5.85% | 3.87% | 60/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.1% | 9.54% | 350% | 29/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -1.24% | -130.39% | -123.35% | 110/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.31% | 19.59% | 55.26% | 65/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.42% | 34.65% | 20.85% | 65/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.83% | 54.64% | -30.64% | 38/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.08% | 26.32% | -8.11% | 82/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.44% | -37.25% | 74.8% | 69/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.54% | 11.65% | 38.8% | 77/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.83% | -1.08% | -43.34% | 64/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 3.23% | 275.58% | -54.35% | 89/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.08% | 32.71% | 211.03% | 61/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.28% | -6.69% | 22.97% | 93/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.85% | 262.28% | 115.12% | 73/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.86% | 102.13% | -83.87% | 107/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.33% | -65.98% | 118.7% | 69/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.44% | 2670.46% | 313.86% | 84/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.14% | -323.53% | 97.18% | 98/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -40.46% | -326.79% | -358.12% | 131/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 15.68% | 14687.74% | 17712.5% | 13/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.09% | 109.44% | -82.75% | 109/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.51% | 218.75% | 105.38% | 94/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -9.48% | -351.43% | -9043.4% | 124/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 0.11% | 39.47% | 111.37% | 99/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | -0.93% | -8372.73% | -682.5% | 103/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.16% | 58.42% | 107.62% | 94/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | -2.1% | 49.4% | -2863.16% | 120/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 0.08% | -83.04% | 790.91% | 96/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | -0.01% | 98.19% | -110.89% | 101/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.1% | 14.77% | 102.43% | 82/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | -4.15% | -108.54% | -1026.34% | 110/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.45% | 611.11% | 173.56% | 77/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.61% | -254.96% | -792.05% | 85/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.09% | 22.22% | 104.42% | 75/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -1.99% | -159.58% | -3258.73% | 99/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.06% | -98.62% | -83.97% | 73/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.39% | -87% | 445.83% | 71/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.07% | -95.31% | -97.84% | 67/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |